Product Description

The Nobivac^® NXT Canine Influenza H3N2 Vaccine utilizes RNA particle technology to produce companion animal vaccines that offer a robust, multi-layered immune protection without the need for adjuvants. This product has been shown to be effective for the vaccination of healthy dogs, 8 weeks of age or older. The vaccine's low-volume, 0.5 mL dose ensures a comfortable experience for pets, while addressing the need for effective protection against canine influenza.

Features & Benefits

• Smaller dose: A low-volume 0.5-mL dose for a gentler vaccine experience
• No extraneous material: Nobivac^® NXT-level protection in a preservative-free, adjuvant-free, thimerosal-free formulation
• Targeted and efficient: Delivers the desired viral sequence to dendritic cells for an enhanced, precise immune response
• Safety and efficacy without compromise: Self-amplification triggers a robust antibody and cellular immune response without the use of an adjuvant or live organisms